Strong execution, Indonesia driving growth, auto transmission pipeline intact
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade A
Hit FY27 >₹500 Cr target on track; delivered 72.5% revenue growth, 145.6% PAT aligned with guidance; EBITDA margin 29.5% at stated threshold.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong execution across all segments with India-to-global customer shift structural tailwind. Indonesia orders (70k units, ₹500+ Cr potential) validating scale model. However, near-term dependent on Indonesia execution and automatic transmission commercialization milestones (expected announcement Dec 2026); concentration risk if either slips.
₹143.1 Cr
Revenue · +72.5% YoY₹26.4 Cr
Reported PAT · +145.6% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Total income ~INR 150 Cr Q2
METINR 148.7 Cr reported; revenue from operations INR 143.1 Cr
EBITDA ~INR 44 Cr, 99% YoY growth
METEBITDA INR 44 Cr, 99% growth confirmed
PAT ~INR 26 Cr, 146% growth
METPAT INR 26.4 Cr, 145.6% growth stated
Transfer case revenue 88% jump YoY
METQ2 INR 80.4 Cr vs INR 42.7 Cr prior year = 88% growth
Indonesia order execution on track, ~70k units over 10-12 months
MET30% delivered Q1; 3,000 units/month pace maintained; ~24k units Mahindra + ~13k Tata supplied Q1-Q2
Earnings quality
What changed since the last call
Automatic transmission timeline
NeutralPrior: H2 FY28 commercialization targeting ₹300-400 Cr minimum. Now: Launch FY28 or early FY29, announcement expected Dec 2026.
EV transmission guidance
UpgradeRamp to ₹10-12 Cr quarterly (vs prior ₹7-8 Cr) maintained; Q2 actual ₹11.4 Cr confirms upper end feasible. Sigma production imminent (H2 FY27).
Indonesia order articulation
UpgradeExecution clarity: 70k units over 10-12 months, 30% delivered Q1; ₹500+ Cr revenue expected FY27. Spillover to FY28 confirmed (won't repeat growth rate next year due to large base).
US facility capex timing
NeutralRemains deliberate, customer-led. No aggressive capex before customer commitments; $5M first phase H2 2028 earliest. Recent equipment exhibition suggests RFQ pipeline active.
The Q&A
Analysts probed Indonesia concentration, EV volume ramp, auto transmission timeline, and segment growth rates. Management held ground with specific numbers (3,000 units/month, Mahindra/Tata split), timelines (FY28/early 29 for AT), and acknowledged execution risks. Tone cautious but confident.
Indonesia order execution — Manthan Jhaveri, Nexus Equity
AnsweredWell over ₹500 Cr FY27 target. H2 will be similar to H1, ~280 Cr. FY28 growth won't match FY27 due to large base order carryover from FY27.
Automatic transmission commercialization — Manthan Jhaveri, Nexus Equity
AnsweredExpected announcement Dec 2026 or early 2027. Two opportunities: small cars and 2+ liter SUV engines. Could move launch late FY28 or early FY29. Multiple customers being worked with.
EV transmission ramp — Avinash Nahata, Param Financial
PartialOriginally earmarked for all programs Tiago onwards (Curvy, etc) but Sigma testing delays shifted to post-Sigma. Sigma production Q1 FY28 onwards. Punch separate contract, coverage post-Sigma broadens range.
Margin guidance sustainability — Manthan Jhaveri, Nexus Equity
PartialEBITDA maintained above 20% threshold since IPO. Scale assists depreciation/fixed cost impact. AT expected higher margin than current (25%+), but ramp-up period may start lower, improving over 3-5 years via cost reduction.
Segment growth trajectory — Karan Gupta, ACMIIL
Answered15-20% baseline growth trajectory preferred. Components run rate ₹140 Cr quarterly possible. Multiple programs in embryonic state (Japanese, European OEMs); India cost advantage vs imports being leveraged.
Indonesia order completion timing — Ronak Jain, Equirus Securities
AnsweredMahindra ~50% executed (24k units Q1-Q2 supplied), Tata ~13k units supplied. 3,000 units/month pace. Mahindra finishes ~Feb, Tata spillover to June FY27.
Capital allocation strategy — Bhavesh, Individual Investor
AnsweredCash intended for product development + capex to reach ₹1,000+ Cr target. No special dividend planned. Balance sheet preserves flexibility.
Guidance
FY27 revenue target well over ₹500 Cr
HighH1 ₹280.2 Cr, H2 expected similar; total ₹560+ Cr on track. Indonesia program (70k units) core driver, execution proceeding as planned.
FY30 aspiration ₹1,000 Cr; FY32/33 potential ₹2,000 Cr
MediumMulti-year roadmap dependent on AT commercialization (FY28/early 29 launch expected), geographic expansion (US, export scale), and EV ramp. Slides 27 projects 15-20% baseline CAGR trajectory.
EBITDA above 20% threshold maintained; currently 29.5% Q2, 30.5% H1
HighStated since IPO; achieved through cycles. Scale supports leverage. Cost headwinds (power, commodity) absorbed via volume mix.
Automatic transmission margin floor ₹25%+
MediumProduct development may start lower (~20%) and improve over 3-5 years via cost reduction and productivity. Indian Tier 1 cost advantage leveraged vs global competition.
US facility: $5M first phase, H2 2028 earliest construction
MediumContingent on customer commitments and RFQ pipeline progression. No aggressive upfront investment; engagement phase underway via Greenville office + recent equipment exhibition.
Risks the call surfaced
Customer concentration
HighIndonesia program ~70k units across two OEMs. Domestic transfer case, EV programs also OEM-led. Diversification into exports and global customers underway but still modest (<50% total).
Automatic transmission execution
HighExpected announcement Dec 2026 / early 2027. Two development streams (small cars, SUV 2+ liter). No formal customer order yet; prototype engagements ongoing. Margin uplift (25%+) and scale (₹1,000 Cr target) predicated on success.
EV transmission demand volatility
MediumSigma program (Tata) approved for series production (H2 FY27); Q2 revenue ₹11.4 Cr showed 87% growth. However, management notes demand/program schedules fluctuate; prototype to series conversion risk embedded. Parallel programs (Punch JV, new Chinese Tier 1) introduce execution risk.
Supply chain & localization risk
MediumSigma testing backlogged at Tata Motors due to bandwidth/priorities; component localization for Sigma relies on Tata Punch contract and Inovance jv. Sigma production timeline (Q1 FY28) is critical path for EV ramp.
Margin pressure from cost inflation
LowCost of power and commodity is rising; management has maintained EBITDA above 20% threshold historically. Scale (Indonesia program, AT ramp) needed to absorb fixed cost and depreciation. If growth stalls, margin compression risk.
Management
Score 8/10. Clear and structured. Provided specific numbers (Indonesia 3,000 units/month, ₹24k Mahindra + ₹13k Tata units supplied). Transparent on execution risks (AT development uncertainty, margin ramp profile). Appropriately cautious on forward projections. Strong track record: delivered 72.5% revenue growth vs ₹500+ Cr target on track; PAT 145.6% growth aligns with 146% claim; EBITDA margin 29.5% at stated threshold. Indonesia ramp (70k units 10-12 months) executing as promised (30% delivered Q1). Slight timeline shift on AT (H2 FY28 target → FY28/early 29) reflects realism.
1 · Dec 2026 / early 2027
Automatic transmission commercial announcement expected; defines FY28/29 ramp
2 · Mid-Dec 2026
Sigma EV transmission testing completion (Tata Motors program validation)
3 · Feb 2027
Mahindra Indonesia order completion expected (50% of 70k unit program)
However, near-term dependent on Indonesia execution and automatic transmission commercialization milestones (expected announcement Dec 2026); concentration risk if either slips.
Informational and educational content only. Not investment advice.